绿竹生物核心产品重组带状疱疹疫苗LZ901于中国启动III期临床试验
Sep 29, 2023 10:31 HKT |  |
|
綠竹生物核心產品重組帶狀皰疹疫苗LZ901於中國啟動III期臨床試驗
Sep 29, 2023 10:30 HKT | |
|
綠竹生物（02480.HK）：重組帶狀皰疹疫苗LZ901啟動三期臨床研究 帶狀皰疹疫苗市場競爭迎新曙光
Sep 29, 2023 10:23 HKT | |
|
绿竹生物（02480.HK）：重组带状疱疹疫苗LZ901启动三期临床研究 带状疱疹疫苗市场竞争迎新曙光
Sep 29, 2023 10:22 HKT | |
|
Hyris Supports Researchers and Developers to Launch Testing Kits via New Onboarding Programs
Sep 27, 2023 17:00 HKT |  |
|
致力于开发中国双抗疗法的生物技术公司武汉友芝友生物于香港联交所主板正式挂牌
Sep 25, 2023 12:47 HKT |  |
|
致力於開發中國雙抗療法的生物技術公司武漢友芝友生物於香港聯交所主板正式掛牌
Sep 25, 2023 12:46 HKT | |
|
A biotechnology company dedicated to developing BsAb-based therapies in China, YZY Biopharma Officially Listed on Main Board of SEHK
Sep 25, 2023 12:45 HKT | |
|
Sirnaomics集团入驻香港科学园 共创香港生物医药发展新篇章
Sep 21, 2023 16:49 HKT |  |
|
Sirnaomics集團入駐香港科學園 共創香港生物醫藥發展新篇章
Sep 21, 2023 16:48 HKT | |
|
Syndesis Health and InSyBio Partner in Predictive Modelling and Biomarker Discovery
Sep 19, 2023 21:00 HKT |  |
|
CGFNS Appoints New Chief Technology Officer to Lead its Digital Transformation
Sep 15, 2023 09:00 HKT |  |
|
Vegan Cats Challenge Carnivorous Expectations
Sep 15, 2023 08:00 HKT |  |
|
专注于中国双抗的开发 武汉友芝友生物宣布于港交所主板上市计划
Sep 13, 2023 11:32 HKT | |
|
專注於中國雙抗的開發 武漢友芝友生物宣佈於港交所主板上市計劃
Sep 13, 2023 11:31 HKT | |
|
Focusing on the development of BsAbs in China, YZY Biopharma Announces Proposed Listing on the Main Board of SEHK
Sep 13, 2023 11:30 HKT | |
|
Ad Scientiam Launches International Study to Assess Disability Progression in Multiple Sclerosis With MSCopilot
Sep 12, 2023 20:00 HKT |  |
|
中国抗体SM17新药研究申请再获国家药监局批准
Sep 12, 2023 09:50 HKT |  |
|
中國抗體SM17新藥研究申請再獲國家藥監局批准
Sep 12, 2023 09:49 HKT | |
|
SinoMab's IND Application of SM17 has once again Received Approval from NAMP
Sep 12, 2023 09:48 HKT | |
|